These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6814135

  • 1. Effects of a dopamine antagonist (metoclopramide) on the release of the adenohypophyseal hormones in amenorrhoeic patients with and without hyperprolactinaemia.
    Seki K, Uesato T, Kato K.
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):166-70. PubMed ID: 6814135
    [Abstract] [Full Text] [Related]

  • 2. Evidence of altered dopaminergic modulation of Prl, LH and TSH secretion in patients with normoprolactinaemic amenorrhoea.
    Hagen C, Petersen K, Djursing H, Andersen AN.
    Acta Endocrinol (Copenh); 1984 May; 106(1):8-14. PubMed ID: 6428118
    [Abstract] [Full Text] [Related]

  • 3. Effects of body weight on responses of serum prolactin to metoclopramide and thyrotrophin-releasing hormone in secondary amenorrhoeic women.
    Takemoto M, Morishita H, Higuchi K, Yoshida J, Aono T.
    Hum Reprod; 1994 May; 9(5):800-5. PubMed ID: 7929725
    [Abstract] [Full Text] [Related]

  • 4. Prl, TSH, GH and LH responses to metoclopramide and breast-feeding in normal and hyperprolactinaemic women.
    Andersen AN, Tabor A.
    Acta Endocrinol (Copenh); 1982 Jun; 100(2):177-83. PubMed ID: 7202316
    [Abstract] [Full Text] [Related]

  • 5. Effects of a dopamine antagonist (metoclopramide) on the release of LH, FSH, TSH and PRL in normal women throughout the menstrual cycle.
    Seki K, Nagata I.
    Acta Endocrinol (Copenh); 1990 Feb; 122(2):211-6. PubMed ID: 2107654
    [Abstract] [Full Text] [Related]

  • 6. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME, Sheehan KL, Casper RF, Yen SS.
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [Abstract] [Full Text] [Related]

  • 7. Possible thyrotrophs insensitivity to dopamine in hyperprolactinaemic amenorrhoeic patients.
    Nyboe Andersen A, Hagen C, Boesgaard S, Eldrup E, Djursing H.
    Horm Metab Res; 1989 Jun; 21(6):328-30. PubMed ID: 2777190
    [Abstract] [Full Text] [Related]

  • 8. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
    Quigley ME, Judd SJ, Gilliland GB, Yen SS.
    J Clin Endocrinol Metab; 1979 Apr; 48(4):718-20. PubMed ID: 429515
    [Abstract] [Full Text] [Related]

  • 9. Functional evaluation of the adenohypophysis with metoclopramide in hyperprolactinemic-amenorrheic women in relation to radiological findings on the sella turcica.
    Seki K, Uesato T, Kato K, Shima K.
    Endocrinol Jpn; 1984 Dec; 31(6):733-9. PubMed ID: 6532792
    [Abstract] [Full Text] [Related]

  • 10. Possible altered dopaminergic modulation of pituitary function in normal-menstruating women with insulin dependent diabetes mellitus (IDDM).
    Djursing H, Carstensen L, Hagen C, Andersen AN.
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):450-5. PubMed ID: 6440390
    [Abstract] [Full Text] [Related]

  • 11. Metoclopramide effect on serum prolactin LH and FSH in patients with polycystic ovary syndrome.
    Prelević GM, Würzburger MI, Perić LA.
    J Endocrinol Invest; 1988 Apr; 11(4):255-9. PubMed ID: 3137253
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of lisuride hydrogen maleate on anterior pituitary hormones, oestradiol and cortisol in normal and hyperprolactinaemic women.
    Koizumi K, Aono T, Kurachi K.
    Eur J Obstet Gynecol Reprod Biol; 1985 Jul; 20(1):19-26. PubMed ID: 3928413
    [Abstract] [Full Text] [Related]

  • 16. Different dopaminergic control of plasma luteinizing hormone, follicle-stimulating hormone and prolactin in ovulatory and postmenopausal women: effect of ovariectomy.
    De Leo V, Petraglia F, Bruno MG, Lanzetta D, Inaudi P, D'Antona N.
    Gynecol Obstet Invest; 1989 Jul; 27(2):94-8. PubMed ID: 2499519
    [Abstract] [Full Text] [Related]

  • 17. Depressed follicle-stimulating hormone, luteinizing hormone, and prolactin responses to the luteinizing hormone-releasing hormone, thyrotropin-releasing hormone, and metoclopramide test in endurance runners in the hard-training season.
    Ronkainen H.
    Fertil Steril; 1985 Dec; 44(6):755-9. PubMed ID: 3935485
    [Abstract] [Full Text] [Related]

  • 18. Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus.
    Djursing H, Hagen C, Nyholm HC, Carstensen L, Andersen AN.
    J Clin Endocrinol Metab; 1983 May; 56(5):1016-21. PubMed ID: 6403566
    [Abstract] [Full Text] [Related]

  • 19. Dopaminergic control of gonadotrophin secretion in normal women and in patients with pathological hyperprolactinaemia.
    Ho KY, Smythe GA, Lazarus L.
    Clin Endocrinol (Oxf); 1984 Jan; 20(1):53-63. PubMed ID: 6420095
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.